The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma.
Ito Y, Monden M, Takeda T, Eguchi H, Umeshita K, Nagano H, Nakamori S, Dono K, Sakon M, Nakamura M, Tsujimoto M, Nakahara M, Nakao K, Yokosaki Y, Matsuura N.
Ito Y, et al. Among authors: nagano h.
Br J Cancer. 2000 Mar;82(6):1211-7. doi: 10.1054/bjoc.1999.1065.
Br J Cancer. 2000.
PMID: 10735508
Free PMC article.